BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 30428334)

  • 1. Targeted delivery of intranasally administered nanoparticles-mediated neuroprotective peptide NR2B9c to brain and neuron for treatment of ischemic stroke.
    Li R; Huang Y; Chen L; Zhou H; Zhang M; Chang L; Shen H; Zhou M; Su P; Zhu D
    Nanomedicine; 2019 Jun; 18():380-390. PubMed ID: 30428334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed Administration of Tat-HA-NR2B9c Promotes Recovery After Stroke in Rats.
    Zhou HH; Tang Y; Zhang XY; Luo CX; Gao LY; Wu HY; Chang L; Zhu DY
    Stroke; 2015 May; 46(5):1352-8. PubMed ID: 25851770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration.
    Gao X; Wu B; Zhang Q; Chen J; Zhu J; Zhang W; Rong Z; Chen H; Jiang X
    J Control Release; 2007 Aug; 121(3):156-67. PubMed ID: 17628165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioengineered Boronic Ester Modified Dextran Polymer Nanoparticles as Reactive Oxygen Species Responsive Nanocarrier for Ischemic Stroke Treatment.
    Lv W; Xu J; Wang X; Li X; Xu Q; Xin H
    ACS Nano; 2018 Jun; 12(6):5417-5426. PubMed ID: 29869497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nose-to-brain transport pathways of wheat germ agglutinin conjugated PEG-PLA nanoparticles.
    Liu Q; Shen Y; Chen J; Gao X; Feng C; Wang L; Zhang Q; Jiang X
    Pharm Res; 2012 Feb; 29(2):546-58. PubMed ID: 22167350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration.
    Liu Z; Jiang M; Kang T; Miao D; Gu G; Song Q; Yao L; Hu Q; Tu Y; Pang Z; Chen H; Jiang X; Gao X; Chen J
    Biomaterials; 2013 May; 34(15):3870-81. PubMed ID: 23453061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of wheat germ agglutinin density on cellular uptake and toxicity of wheat germ agglutinin conjugated PEG-PLA nanoparticles in Calu-3 cells.
    Shen Y; Chen J; Liu Q; Feng C; Gao X; Wang L; Zhang Q; Jiang X
    Int J Pharm; 2011 Jul; 413(1-2):184-93. PubMed ID: 21550388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection by freezing ischemic penumbra evolution without cerebral blood flow augmentation with a postsynaptic density-95 protein inhibitor.
    Bråtane BT; Cui H; Cook DJ; Bouley J; Tymianski M; Fisher M
    Stroke; 2011 Nov; 42(11):3265-70. PubMed ID: 21903963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncoupling PSD-95 interactions leads to rapid recovery of cortical function after focal stroke.
    Srejic LR; Hutchison WD; Aarts MM
    J Cereb Blood Flow Metab; 2013 Dec; 33(12):1937-43. PubMed ID: 24022623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo toxicity and immunogenicity of wheat germ agglutinin conjugated poly(ethylene glycol)-poly(lactic acid) nanoparticles for intranasal delivery to the brain.
    Liu Q; Shao X; Chen J; Shen Y; Feng C; Gao X; Zhao Y; Li J; Zhang Q; Jiang X
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):79-84. PubMed ID: 21163285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A beacon of hope in stroke therapy-Blockade of pathologically activated cellular events in excitotoxic neuronal death as potential neuroprotective strategies.
    Hoque A; Hossain MI; Ameen SS; Ang CS; Williamson N; Ng DC; Chueh AC; Roulston C; Cheng HC
    Pharmacol Ther; 2016 Apr; 160():159-79. PubMed ID: 26899498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bio-clickable, small extracellular vesicles-COCKTAIL therapy for ischemic stroke.
    Haroon K; Ruan H; Zheng H; Wu S; Liu Z; Shi X; Tang Y; Yang GY; Zhang Z
    J Control Release; 2023 Nov; 363():585-596. PubMed ID: 37793483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal administration of osteopontin peptide mimetics confers neuroprotection in stroke.
    Doyle KP; Yang T; Lessov NS; Ciesielski TM; Stevens SL; Simon RP; King JS; Stenzel-Poore MP
    J Cereb Blood Flow Metab; 2008 Jun; 28(6):1235-48. PubMed ID: 18364727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal Delivery of Granulocyte Colony-Stimulating Factor Enhances Its Neuroprotective Effects Against Ischemic Brain Injury in Rats.
    Sun BL; He MQ; Han XY; Sun JY; Yang MF; Yuan H; Fan CD; Zhang S; Mao LL; Li DW; Zhang ZY; Zheng CB; Yang XY; Li YV; Stetler RA; Chen J; Zhang F
    Mol Neurobiol; 2016 Jan; 53(1):320-330. PubMed ID: 25432887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted delivery of polypeptide nanoparticle for treatment of traumatic brain injury.
    Wu P; Zhao H; Gou X; Wu X; Zhang S; Deng G; Chen Q
    Int J Nanomedicine; 2019; 14():4059-4069. PubMed ID: 31213815
    [No Abstract]   [Full Text] [Related]  

  • 16. Poly(lactic acid) nanoparticles coated with combined WGA and water-soluble chitosan for mucosal delivery of β-galactosidase.
    Sheng Y; He H; Zou H
    Drug Deliv; 2014 Aug; 21(5):370-8. PubMed ID: 24797098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Neuroprotective Peptide Poly-Arginine-12 (R12) Reduces Cell Surface Levels of NMDA NR2B Receptor Subunit in Cortical Neurons; Investigation into the Involvement of Endocytic Mechanisms.
    MacDougall G; Anderton RS; Edwards AB; Knuckey NW; Meloni BP
    J Mol Neurosci; 2017 Feb; 61(2):235-246. PubMed ID: 27866326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selectivity, efficacy and toxicity studies of UCCB01-144, a dimeric neuroprotective PSD-95 inhibitor.
    Bach A; Clausen BH; Kristensen LK; Andersen MG; Ellman DG; Hansen PBL; Hasseldam H; Heitz M; Özcelik D; Tuck EJ; Kopanitsa MV; Grant SGN; Lykke-Hartmann K; Johansen FF; Lambertsen KL; Strømgaard K
    Neuropharmacology; 2019 May; 150():100-111. PubMed ID: 30836092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal Delivery of Exendin-4 Confers Neuroprotective Effect Against Cerebral Ischemia in Mice.
    Zhang H; Meng J; Zhou S; Liu Y; Qu D; Wang L; Li X; Wang N; Luo X; Ma X
    AAPS J; 2016 Mar; 18(2):385-94. PubMed ID: 26689204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.